Novartis: Betting on Life Sciences Harvard Case Solution & Analysis

The merger of Ciba-Geigy and Sandoz is based on genomic interaction in the field of health, agriculture and food additives. How to build on the strength of individual units and to create synergy that will continue to lead Novartis "is the issue facing the company." Hide
by Ray A. Goldberg, Carin-Isabel Knoop, Srinivas Ramdas Sunder Source: Harvard Business School 22 pages. Publication Date: December 10, 1998. Prod. #: 599076-PDF-ENG

Novartis:  Betting on Life Sciences Case Solution Other Similar Case Solutions like

Novartis: Betting on Life Sciences

Share This